FOLH1 and neoplasm: Despite having a lower uptake in the LNCaP tumor compared to [68Ga]Ga-PSMA-617 (16.7 ± 2.30 %ID/g), [68Ga]Ga-AV01084 and [68Ga]Ga-AV01088 (9.05 ± 1.54 and 8.85 ± 1.25 %ID/g, respectively) actually had better tumor uptake than our three previously reported bispecific PSMA/FAP tracers ([68Ga]Ga-AV01017, [68Ga]Ga-AV01030 and [68Ga]AV01038) (4.25–5.17 %ID/g) [28].